로그인|회원가입|고객센터|HBR Korea
페이지 맨 위로 이동
검색버튼 메뉴버튼

Bio / AI

Edgecare Selected for Scale-Up TIPS by Ministry

Dong-A Ilbo | Updated 2025.11.26
Research and development project worth a total of KRW 1.5 billion… BSK Investment links KRW 1 billion investment
EdgeCare's ultrasound-based wearable bladder monitoring device ‘EdgeFlow UW20’
EdgeCare (CEO Yangmo Yoo) announced on the 26th that it has been finally selected for the Ministry of SMEs and Startups' ‘Scale-up TIPS R&D Project’. The selected research and development project is the ‘Development of a Wearable Ultrasound-based Personalized Urinary Disorder Management Solution’, a program that supports scale-up by linking private investment and government R&D to promising SMEs with technological capabilities. EdgeCare will lead the project, with Yonsei University's Industry-Academic Cooperation Foundation (led by Professor Wonseok Jang) participating as a joint research institution.

The project will be carried out over a total of 36 months from November 2025 to October 2028, with a total R&D budget of approximately KRW 1.5 billion. Of this, the government contribution is in the KRW 1.1 billion range. BSK Investment evaluated that EdgeCare's deep learning-based ultrasound technology has high potential to address unmet needs in the medical field and reduce monitoring gaps between home and hospital.

Through this project, EdgeCare will develop the next-generation wearable bladder monitoring solution ‘EdgeFlow UW40’. The UW40 is an advanced model based on the existing hospital product UW20, featuring ultra-small and ultra-thin ultrasound sensor structures that allow continuous monitoring of bladder conditions in a home environment. It includes deep learning-based individual and posture-specific bladder volume measurement, urination pattern analysis, and personalized rehabilitation training support functions, and is expected to evolve into an integrated solution supporting rehabilitation based on bladder volume information.

It is particularly expected to present a new management paradigm encompassing monitoring and rehabilitation for patient groups such as those with chronic urinary retention and postoperative urinary retention, where existing management solutions have been insufficient. CEO Yangmo Yoo stated, “Real-time, non-invasive, continuous patient monitoring technology based on AI and ultrasound patches is a key technology that will significantly change the medical field. The R&D capabilities and private investment secured through this Scale-up TIPS selection will further accelerate EdgeCare's growth.”

Junki Lee, Executive Director of BSK Investment, stated, “EdgeCare is a company that aligns with the new trend of non-invasive, continuous measurement in medical diagnostic devices, and has the potential to lead the market based on global-level ultrasound technology. We will actively support growth acceleration and global expansion through Scale-up TIPS.”

Through the execution of this project, EdgeCare plans to contribute to improving the quality of life for patients with chronic urinary disorders, preventing complications, and reducing medical and social costs, while further accelerating growth through product commercialization and global market expansion.

Kim Sang-jun

AI-translated with ChatGPT. Provided as is; original Korean text prevails.
Popular News

경영·경제 질문은 AI 비서에게,
무엇이든 물어보세요.

Click!